Awareness about clostridium difficile infection among internal medicine residents in the United States

Minerva Gastroenterologica e Dietologica

Volumn 57, Issue 3, 2011, Pages 231-240

  Navaneethan, U ^a   Schauer, D P ^a   Giannella, R A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Clostridium difficile; Drug therapy; Knowledge

Indexed keywords

ARTICLE; AWARENESS; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE INFECTION; ENTERITIS; HEALTH SURVEY; HUMAN; INTERNAL MEDICINE; LICENSING; MEDICAL EDUCATION; OUTCOME ASSESSMENT; OUTPATIENT; POSTGRADUATE EDUCATION; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; RESIDENT; RISK; UNITED STATES;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; FACULTY, MEDICAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; INTERNAL MEDICINE; INTERNSHIP AND RESIDENCY; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 80755169767     PISSN: 00264776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudo membranous colitis due to toxin-producing clostridia. N Engl J Med 1978;298:531.
2. Bartlett JG. Historical perspectives on studies of Clostridium difficile and Clostridium difficile infection. Clin Infec Dis 2008;46 (Suppl 1).
3. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-84. (Pubitemid 41338761)
4. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP et al. Emergence of an epidemic, toxin gene variant strain of Clostridium difficile responsible for outbreaks in the United States between 2000 and 2004. N Engl J Med 2005;353:2433-41.
5. Kazakova SV, Ware K, Baughman B, Bilukha O, Paradis A, Sears S et al. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 2006;166:2518-24. (Pubitemid 44913237)
6. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol 2007;28:1219-27. (Pubitemid 47596558)
7. Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile - Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008;57:340-3.
8. CDC. Severe Clostridium difficile - associated disease in populations previously at low risk - four states, 2005. MMWR 2005;54:1201-5.
9. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008;57;205-10. (Pubitemid 351158048)
10. Navaneethan U, Giannella RA. Thinking beyond the colon-small bowel involvement in clostridium difficile infection. Gut Pathog 2009;1:7.
11. Infectious Diseases Society of America 45th Annual Meeting: Abstracts 1165, 1166, 1167. Presented October 6, 2007.
12. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg 2002;137:1096-100. (Pubitemid 35155238)
13. Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363-72. (Pubitemid 34183887)
14. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, Forget K et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004;171:466-72. (Pubitemid 39179608)
15. Wysowski DK. Increase in deaths related to enterocolitis due to Clostridium difficile in the United States, 1999-2002. Public Health Rep 2006;121:361-2. (Pubitemid 44186393)
16. MacDougall C, Guglielmo BJ, Maselli J, Gonzales R. Antimicrobial drug prescribing for pneumonia in ambulatory care. Emerg Infect Dis 2005;11:380-4. (Pubitemid 40315722)
17. Rodemann JF, Dubberke ER, Reske KA, Seo da H, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:339-44. (Pubitemid 46401530)
18. Issa M, Vijayapal A, Graham MB, Beaulieu DB, Otterson MF, Lundeen S et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007;5:345-51. (Pubitemid 46401531)
19. Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008;103:1443-50. (Pubitemid 351813903)
20. Pepin J, Vo TT, Boutros M, Marcotte E, Dial S, Dubé S et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum 2009;52:400-5.
21. Tedesco FJ, Corless JK, Brownstein RE. Rectal sparing in antibiotic associated pseudomembranous colitis: a prospective study. Gastroenterology 1982;83:1259-60. (Pubitemid 13235926)
22. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302-7. (Pubitemid 47101025)
23. Miller MA. Clinical management of Clostridium difficile associated disease. Clin Infect Dis 2007;45(Suppl 2):S122-8. (Pubitemid 47328626)
24. Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J Jr. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459-77.
25. Kellerman SE, Herold J. Physician response to surveys: a review of the literature. Am J Prev Med 2001;20:61-7. (Pubitemid 32013069)